Latest news

All.Can announces Board of Directors 2025-2027 and Christobel Saunders as All.Can President

We’re pleased to announce All.Can International’s new Board of Directors, further to their election and endorsement at All.Can’s Annual General Meeting (AGM)…

Read More

Latest news

Strengthening Cancer Prevention in Europe: EFPIA Oncology Platform and All.Can Release Report on Screening Implementation

The EFPIA Oncology Platform (EOP) and All.Can are proud to release their report highlighting a successful collaboration aimed at accelerating the implementation of the EU Council Recommendation on cancer screening…
Read more

All.Can Shares Expertise at Italian Workshop on Cancer Governance and Care Efficiency

On 24 June, All.Can International CEO Eduardo Pisani joined the online workshop “Synergies between Italy and Europe in the Fight Against Cancer – Cancer Governance and Management at European, National,…
Read more

ELLOK – Hellenic Cancer Federation hosts its 2nd Synergies Forum on Cancer

ELLOK will host its “2nd Synergies Forum on Cancer Policy, Research & Funding Strategies” in Athens, at the Grand Athens Wyndham Hotel, in 30 June-1 July 2025. The Forum aims…
Read more

All.Can Poland Participates in the Inaugural Cancer Mission Fair in Warsaw

All.Can Poland proudly participated in the first-ever Cancer Mission Fair, held from 20–22 May in Warsaw, as part of the ECHoS project in collaboration with the European Commission’s EU Cancer…
Read more

All.Can welcomes a new member – FUNSALUD – Fundación Mexicana para la Salud

All.Can International is pleased to announce that FUNSALUD has recently joined our organisation as a member. FUNSALUD is a think tank that has been able to position in the public…
Read more

Bladder Cancer Awareness Month 2025

Bladder Cancer Awareness Month 2025: Feeling Unsure? Get Checked. This May, the World Bladder Cancer Patient Coalition (WBCPC) is launching Bladder Cancer Awareness Month 2025 under the theme “Feeling Unsure? Get Checked”. The campaign highlights the…
Read more

All.Can welcomes a new member – Pfizer

All.Can International is pleased to announce that Pfizer has recently joined our organisation as a member. Pfizer Inc. is a leading global biopharmaceutical company committed to discovering, developing, and delivering…
Read more

All.Can Responds to European Parliament Consultations on Rare Diseases and Women’s Health

In early 2025, the European Parliament’s Committee on Public Health (SANT) launched two key public consultations to gather input on rare diseases and women’s health, both now closed. Marking Rare…
Read more

Making ‘Early’ Our Mission to Beat Cancer

As an Advisory Group member of Mission Early, All.Can is proud to share recent progress in advancing early cancer care across Europe. Mission Early has published a new op-ed in The…
Read more